SlideShare ist ein Scribd-Unternehmen logo
1 von 22
The State of Clinical  Development  -  Globalization January 11, 2011 Doug Peddicord, PhD Executive Director
ACRO ,[object Object],[object Object],[object Object],[object Object],[object Object]
The Top CROs  (as of 10-16-11) Sources: Scrip INC Kendle Pharmanet I3 InVentiv Health
Major Pharma and CRO Clinical Headcount Source: Tufts CSDD analysis
ACRO Member Company Expansion: 2010
ACRO Member Company Expansion: 2011
  Increasing Global Site Dispersion Source: Tufts CSDD analysis of Industry-Funded Trials Registered on clinicaltrials.gov   2002-2006 (Mean # of Countries) 2006-2010 (Mean # of Countries) Phase I Clinical Trial 2 2 Phase II Clinical Trial 11 18 Phase III Clinical Trial 19 34
A Global Enterprise – Current and Recently Completed Trials Source: ClinicalTrials.gov
Why Conduct Clinical Trials Around The World? ,[object Object],[object Object],[object Object],[object Object]
Globalization - Advantages ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Globalization - Challenges ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Globalization - Concerns ,[object Object],[object Object],[object Object],[object Object]
NBAC 2001 Report – selected recommendations ,[object Object],[object Object],[object Object],[object Object]
More from NBAC ,[object Object],[object Object],[object Object],[object Object],[object Object]
Going Beyond Business Considerations and Policy Recommendations ,[object Object],[object Object]
Comparison of Participating Sites and Subjects Across Various Regions
Demographic and Other Study Details ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Summary of Findings  ,[object Object],[object Object],[object Object]
The Next Research Project: 2011-2012 ,[object Object],[object Object],[object Object],[object Object]
Assessing Global Quality at the Investigator/Site Level ,[object Object],[object Object],[object Object]
Aligning The Incentives ,[object Object],[object Object],[object Object]
Thank You! ,[object Object],[object Object],[object Object],[object Object]

Weitere ähnliche Inhalte

Was ist angesagt?

Clinical sas programmer
Clinical sas programmerClinical sas programmer
Clinical sas programmer
ray4hz
 
Discussant: Prioritizing Evidence Syntheses
Discussant: Prioritizing Evidence SynthesesDiscussant: Prioritizing Evidence Syntheses
Discussant: Prioritizing Evidence Syntheses
Cochrane.Collaboration
 

Was ist angesagt? (20)

Towse NDDP implications for drug development
Towse NDDP implications for drug developmentTowse NDDP implications for drug development
Towse NDDP implications for drug development
 
PMED: APPM Workshop: From Real World Data to Real World Evidence - Richard Zi...
PMED: APPM Workshop: From Real World Data to Real World Evidence - Richard Zi...PMED: APPM Workshop: From Real World Data to Real World Evidence - Richard Zi...
PMED: APPM Workshop: From Real World Data to Real World Evidence - Richard Zi...
 
Major healthcare delivery trends 2015
Major healthcare delivery trends 2015Major healthcare delivery trends 2015
Major healthcare delivery trends 2015
 
Webinar: Oncology Trial Recruitment: Challenging Indications and Challenging ...
Webinar: Oncology Trial Recruitment: Challenging Indications and Challenging ...Webinar: Oncology Trial Recruitment: Challenging Indications and Challenging ...
Webinar: Oncology Trial Recruitment: Challenging Indications and Challenging ...
 
Trends in clinical research and career gd 09_may20
Trends in clinical research and career gd 09_may20Trends in clinical research and career gd 09_may20
Trends in clinical research and career gd 09_may20
 
Clinical sas programmer
Clinical sas programmerClinical sas programmer
Clinical sas programmer
 
Best Practices to Risk Based Data Integrity at Data Integrity Conference, Lon...
Best Practices to Risk Based Data Integrity at Data Integrity Conference, Lon...Best Practices to Risk Based Data Integrity at Data Integrity Conference, Lon...
Best Practices to Risk Based Data Integrity at Data Integrity Conference, Lon...
 
Clinical trails
Clinical trails Clinical trails
Clinical trails
 
Webinar: Special Considerations for Managing Immuno-Oncology Studies: A New P...
Webinar: Special Considerations for Managing Immuno-Oncology Studies: A New P...Webinar: Special Considerations for Managing Immuno-Oncology Studies: A New P...
Webinar: Special Considerations for Managing Immuno-Oncology Studies: A New P...
 
Plan Early for Late Phase Clinical Trials
Plan Early for Late Phase Clinical TrialsPlan Early for Late Phase Clinical Trials
Plan Early for Late Phase Clinical Trials
 
Clinical Data Management
Clinical Data ManagementClinical Data Management
Clinical Data Management
 
Translational medicine
Translational medicineTranslational medicine
Translational medicine
 
Discussant: Prioritizing Evidence Syntheses
Discussant: Prioritizing Evidence SynthesesDiscussant: Prioritizing Evidence Syntheses
Discussant: Prioritizing Evidence Syntheses
 
Professor Dipak Kalra Digital Health Assembly 2015
Professor Dipak Kalra Digital Health Assembly 2015Professor Dipak Kalra Digital Health Assembly 2015
Professor Dipak Kalra Digital Health Assembly 2015
 
Cortellis for Clinical Trials Intelligence Large Group Training
Cortellis for Clinical Trials Intelligence Large Group TrainingCortellis for Clinical Trials Intelligence Large Group Training
Cortellis for Clinical Trials Intelligence Large Group Training
 
Statistical outliers in BE Studies DIA 12 april 2019
Statistical outliers in BE Studies DIA 12 april 2019Statistical outliers in BE Studies DIA 12 april 2019
Statistical outliers in BE Studies DIA 12 april 2019
 
Using the right E (Efficacy vs. Effectiveness) in Cost-Effectiveness / Afford...
Using the right E (Efficacy vs. Effectiveness) in Cost-Effectiveness / Afford...Using the right E (Efficacy vs. Effectiveness) in Cost-Effectiveness / Afford...
Using the right E (Efficacy vs. Effectiveness) in Cost-Effectiveness / Afford...
 
Digital Footprint: A Step in Which Direction?
Digital Footprint: A Step in Which Direction?Digital Footprint: A Step in Which Direction?
Digital Footprint: A Step in Which Direction?
 
PMED: APPM Workshop: Challenges in Using Bayesian Analysis Approaches for Reg...
PMED: APPM Workshop: Challenges in Using Bayesian Analysis Approaches for Reg...PMED: APPM Workshop: Challenges in Using Bayesian Analysis Approaches for Reg...
PMED: APPM Workshop: Challenges in Using Bayesian Analysis Approaches for Reg...
 
Applying Innovative Solutions to Canada’s Orphan Product Access Strategy: Mar...
Applying Innovative Solutions to Canada’s Orphan Product Access Strategy: Mar...Applying Innovative Solutions to Canada’s Orphan Product Access Strategy: Mar...
Applying Innovative Solutions to Canada’s Orphan Product Access Strategy: Mar...
 

Andere mochten auch

Andere mochten auch (9)

Investigator Grants
Investigator GrantsInvestigator Grants
Investigator Grants
 
Annual State of Clinical Development Costs
Annual State of Clinical Development CostsAnnual State of Clinical Development Costs
Annual State of Clinical Development Costs
 
SOC & Research BIlling Compliance
SOC & Research BIlling ComplianceSOC & Research BIlling Compliance
SOC & Research BIlling Compliance
 
Working with Countries that are Difficult to Negotiate with
Working with Countries that are Difficult to Negotiate withWorking with Countries that are Difficult to Negotiate with
Working with Countries that are Difficult to Negotiate with
 
Observational Studies: Strategic, Operational and Budgetary Considerations
Observational Studies: Strategic, Operational and Budgetary ConsiderationsObservational Studies: Strategic, Operational and Budgetary Considerations
Observational Studies: Strategic, Operational and Budgetary Considerations
 
Future Challenges for Big Pharma
Future Challenges for Big PharmaFuture Challenges for Big Pharma
Future Challenges for Big Pharma
 
Late Phase Study Planning and Budgeting
Late Phase Study Planning and BudgetingLate Phase Study Planning and Budgeting
Late Phase Study Planning and Budgeting
 
Clinical rd presentation 10 jan2012_sharma
Clinical rd presentation 10 jan2012_sharmaClinical rd presentation 10 jan2012_sharma
Clinical rd presentation 10 jan2012_sharma
 
R&D Productivity and Costs in Today's Health Care Arena - Pat Audet
R&D Productivity and Costs in Today's Health Care Arena - Pat AudetR&D Productivity and Costs in Today's Health Care Arena - Pat Audet
R&D Productivity and Costs in Today's Health Care Arena - Pat Audet
 

Ähnlich wie The State of Clinical Development - Globalization

Worldwide comprehensive study of guideline on clinical trial
Worldwide comprehensive study of guideline on clinical trialWorldwide comprehensive study of guideline on clinical trial
Worldwide comprehensive study of guideline on clinical trial
RGPV BHOPAL
 
Globalization Of Clinical Trials 2010 Josep M. Badenas
Globalization Of Clinical Trials 2010   Josep M. BadenasGlobalization Of Clinical Trials 2010   Josep M. Badenas
Globalization Of Clinical Trials 2010 Josep M. Badenas
josepmariabadenas
 
Future Challenges of Clinical Development; a View from the CRO - Hani Zaki
Future Challenges of Clinical Development; a View from the CRO - Hani ZakiFuture Challenges of Clinical Development; a View from the CRO - Hani Zaki
Future Challenges of Clinical Development; a View from the CRO - Hani Zaki
TTC, llc
 
Future Challenges of Clinical Development; a View from the CRO - Hani Zaki
Future Challenges of Clinical Development; a View from the CRO - Hani ZakiFuture Challenges of Clinical Development; a View from the CRO - Hani Zaki
Future Challenges of Clinical Development; a View from the CRO - Hani Zaki
TTC, llc
 
Hepatitis C Drugs - Evidence to Demonstrate Effectiveness & Value
Hepatitis C Drugs - Evidence to Demonstrate Effectiveness & ValueHepatitis C Drugs - Evidence to Demonstrate Effectiveness & Value
Hepatitis C Drugs - Evidence to Demonstrate Effectiveness & Value
Center for Medical Technology Policy
 
Exodon - Company Profile and Service Overview
Exodon - Company Profile and Service OverviewExodon - Company Profile and Service Overview
Exodon - Company Profile and Service Overview
Paul Ernest de Leon
 
Project Management_DM Presentation
Project Management_DM PresentationProject Management_DM Presentation
Project Management_DM Presentation
Daniela Margiotta
 

Ähnlich wie The State of Clinical Development - Globalization (20)

Worldwide comprehensive study of guideline on clinical trial
Worldwide comprehensive study of guideline on clinical trialWorldwide comprehensive study of guideline on clinical trial
Worldwide comprehensive study of guideline on clinical trial
 
Globalization Of Clinical Trials 2010 Josep M. Badenas
Globalization Of Clinical Trials 2010   Josep M. BadenasGlobalization Of Clinical Trials 2010   Josep M. Badenas
Globalization Of Clinical Trials 2010 Josep M. Badenas
 
Foreign clinical trials (FCTs) for life science startups
Foreign clinical trials (FCTs) for life science startupsForeign clinical trials (FCTs) for life science startups
Foreign clinical trials (FCTs) for life science startups
 
SDTM Fnal Detail Training
SDTM Fnal Detail TrainingSDTM Fnal Detail Training
SDTM Fnal Detail Training
 
Siobhan gaynor patientclinicalresearchtalkdec15
Siobhan gaynor   patientclinicalresearchtalkdec15Siobhan gaynor   patientclinicalresearchtalkdec15
Siobhan gaynor patientclinicalresearchtalkdec15
 
Four strategies to upgrade clinical trial quality in this computerized world ...
Four strategies to upgrade clinical trial quality in this computerized world ...Four strategies to upgrade clinical trial quality in this computerized world ...
Four strategies to upgrade clinical trial quality in this computerized world ...
 
Clinical research
Clinical researchClinical research
Clinical research
 
Elite research network 2011
Elite research network   2011Elite research network   2011
Elite research network 2011
 
Future Challenges of Clinical Development; a View from the CRO - Hani Zaki
Future Challenges of Clinical Development; a View from the CRO - Hani ZakiFuture Challenges of Clinical Development; a View from the CRO - Hani Zaki
Future Challenges of Clinical Development; a View from the CRO - Hani Zaki
 
Future Challenges of Clinical Development; a View from the CRO - Hani Zaki
Future Challenges of Clinical Development; a View from the CRO - Hani ZakiFuture Challenges of Clinical Development; a View from the CRO - Hani Zaki
Future Challenges of Clinical Development; a View from the CRO - Hani Zaki
 
Hepatitis C Drugs - Evidence to Demonstrate Effectiveness & Value
Hepatitis C Drugs - Evidence to Demonstrate Effectiveness & ValueHepatitis C Drugs - Evidence to Demonstrate Effectiveness & Value
Hepatitis C Drugs - Evidence to Demonstrate Effectiveness & Value
 
Exodon - Company Profile and Service Overview
Exodon - Company Profile and Service OverviewExodon - Company Profile and Service Overview
Exodon - Company Profile and Service Overview
 
What Qualities do Providers Identify as Best for Point of Care STI Tests and ...
What Qualities do Providers Identify as Best for Point of Care STI Tests and ...What Qualities do Providers Identify as Best for Point of Care STI Tests and ...
What Qualities do Providers Identify as Best for Point of Care STI Tests and ...
 
A CTTI Survey of Current Monitoring Practices
A CTTI Survey of Current Monitoring PracticesA CTTI Survey of Current Monitoring Practices
A CTTI Survey of Current Monitoring Practices
 
Cost on development of new drug
Cost on development of new drugCost on development of new drug
Cost on development of new drug
 
Project Management_DM Presentation
Project Management_DM PresentationProject Management_DM Presentation
Project Management_DM Presentation
 
CURE OM Patient Registry Update - 2019 CURE OM Symposium
CURE OM Patient Registry Update - 2019 CURE OM SymposiumCURE OM Patient Registry Update - 2019 CURE OM Symposium
CURE OM Patient Registry Update - 2019 CURE OM Symposium
 
Clinical Solutions White Paper
Clinical Solutions White PaperClinical Solutions White Paper
Clinical Solutions White Paper
 
3.clinical trials
3.clinical trials3.clinical trials
3.clinical trials
 
Soil_ Erosion.ppt
Soil_ Erosion.pptSoil_ Erosion.ppt
Soil_ Erosion.ppt
 

Mehr von TTC, llc

Compliance and FMV - Seth Whitelaw
Compliance and FMV - Seth WhitelawCompliance and FMV - Seth Whitelaw
Compliance and FMV - Seth Whitelaw
TTC, llc
 
Compliance and FMV - Karen Lowney
Compliance and FMV - Karen LowneyCompliance and FMV - Karen Lowney
Compliance and FMV - Karen Lowney
TTC, llc
 
Standard of Care - Donna Beardsworth
Standard of Care - Donna BeardsworthStandard of Care - Donna Beardsworth
Standard of Care - Donna Beardsworth
TTC, llc
 
Emerging Regions - Alan Braverman
Emerging Regions - Alan BravermanEmerging Regions - Alan Braverman
Emerging Regions - Alan Braverman
TTC, llc
 
Clinical Trial Costs in Emerging Geographies - Stephen Porter
Clinical Trial Costs in Emerging Geographies - Stephen PorterClinical Trial Costs in Emerging Geographies - Stephen Porter
Clinical Trial Costs in Emerging Geographies - Stephen Porter
TTC, llc
 
Effective Global Site Budgeting and Cost Management - Natalie Gosciminski
Effective Global Site Budgeting and Cost Management - Natalie GosciminskiEffective Global Site Budgeting and Cost Management - Natalie Gosciminski
Effective Global Site Budgeting and Cost Management - Natalie Gosciminski
TTC, llc
 
Effective Global Site Budgeting and Cost Management - Forrest Swope
Effective Global Site Budgeting and Cost Management - Forrest SwopeEffective Global Site Budgeting and Cost Management - Forrest Swope
Effective Global Site Budgeting and Cost Management - Forrest Swope
TTC, llc
 
Payment Practices, FMV, and Study Performance - Harold Glass
Payment Practices, FMV, and Study Performance - Harold GlassPayment Practices, FMV, and Study Performance - Harold Glass
Payment Practices, FMV, and Study Performance - Harold Glass
TTC, llc
 

Mehr von TTC, llc (13)

Investigator-Initiated Studies: Two Stories from the NIH
Investigator-Initiated Studies: Two Stories from the NIHInvestigator-Initiated Studies: Two Stories from the NIH
Investigator-Initiated Studies: Two Stories from the NIH
 
Phase IIIB & IV Studies Reflect the Evolution of Industry Needs & Market Real...
Phase IIIB & IV Studies Reflect the Evolution of Industry Needs & Market Real...Phase IIIB & IV Studies Reflect the Evolution of Industry Needs & Market Real...
Phase IIIB & IV Studies Reflect the Evolution of Industry Needs & Market Real...
 
Compliance and FMV - Seth Whitelaw
Compliance and FMV - Seth WhitelawCompliance and FMV - Seth Whitelaw
Compliance and FMV - Seth Whitelaw
 
Compliance and FMV - Karen Lowney
Compliance and FMV - Karen LowneyCompliance and FMV - Karen Lowney
Compliance and FMV - Karen Lowney
 
Standard of Care - Donna Beardsworth
Standard of Care - Donna BeardsworthStandard of Care - Donna Beardsworth
Standard of Care - Donna Beardsworth
 
Emerging Regions - Alan Braverman
Emerging Regions - Alan BravermanEmerging Regions - Alan Braverman
Emerging Regions - Alan Braverman
 
Clinical Trial Costs in Emerging Geographies - Stephen Porter
Clinical Trial Costs in Emerging Geographies - Stephen PorterClinical Trial Costs in Emerging Geographies - Stephen Porter
Clinical Trial Costs in Emerging Geographies - Stephen Porter
 
Effective Global Site Budgeting and Cost Management - Natalie Gosciminski
Effective Global Site Budgeting and Cost Management - Natalie GosciminskiEffective Global Site Budgeting and Cost Management - Natalie Gosciminski
Effective Global Site Budgeting and Cost Management - Natalie Gosciminski
 
Effective Global Site Budgeting and Cost Management - Forrest Swope
Effective Global Site Budgeting and Cost Management - Forrest SwopeEffective Global Site Budgeting and Cost Management - Forrest Swope
Effective Global Site Budgeting and Cost Management - Forrest Swope
 
Payment Practices, FMV, and Study Performance - Harold Glass
Payment Practices, FMV, and Study Performance - Harold GlassPayment Practices, FMV, and Study Performance - Harold Glass
Payment Practices, FMV, and Study Performance - Harold Glass
 
Two Worlds - Larry Poli
Two Worlds - Larry PoliTwo Worlds - Larry Poli
Two Worlds - Larry Poli
 
Effective Global Site Budgeting and Cost Management - Holly Squires
Effective Global Site Budgeting and Cost Management  - Holly SquiresEffective Global Site Budgeting and Cost Management  - Holly Squires
Effective Global Site Budgeting and Cost Management - Holly Squires
 
Standard of Care - Ying Jiang
Standard of Care - Ying JiangStandard of Care - Ying Jiang
Standard of Care - Ying Jiang
 

Kürzlich hochgeladen

Al Mizhar Dubai Escorts +971561403006 Escorts Service In Al Mizhar
Al Mizhar Dubai Escorts +971561403006 Escorts Service In Al MizharAl Mizhar Dubai Escorts +971561403006 Escorts Service In Al Mizhar
Al Mizhar Dubai Escorts +971561403006 Escorts Service In Al Mizhar
allensay1
 

Kürzlich hochgeladen (20)

Horngren’s Cost Accounting A Managerial Emphasis, Canadian 9th edition soluti...
Horngren’s Cost Accounting A Managerial Emphasis, Canadian 9th edition soluti...Horngren’s Cost Accounting A Managerial Emphasis, Canadian 9th edition soluti...
Horngren’s Cost Accounting A Managerial Emphasis, Canadian 9th edition soluti...
 
joint cost.pptx COST ACCOUNTING Sixteenth Edition ...
joint cost.pptx  COST ACCOUNTING  Sixteenth Edition                          ...joint cost.pptx  COST ACCOUNTING  Sixteenth Edition                          ...
joint cost.pptx COST ACCOUNTING Sixteenth Edition ...
 
Arti Languages Pre Seed Teaser Deck 2024.pdf
Arti Languages Pre Seed Teaser Deck 2024.pdfArti Languages Pre Seed Teaser Deck 2024.pdf
Arti Languages Pre Seed Teaser Deck 2024.pdf
 
Uneak White's Personal Brand Exploration Presentation
Uneak White's Personal Brand Exploration PresentationUneak White's Personal Brand Exploration Presentation
Uneak White's Personal Brand Exploration Presentation
 
SEO Case Study: How I Increased SEO Traffic & Ranking by 50-60% in 6 Months
SEO Case Study: How I Increased SEO Traffic & Ranking by 50-60%  in 6 MonthsSEO Case Study: How I Increased SEO Traffic & Ranking by 50-60%  in 6 Months
SEO Case Study: How I Increased SEO Traffic & Ranking by 50-60% in 6 Months
 
Chennai Call Gril 80022//12248 Only For Sex And High Profile Best Gril Sex Av...
Chennai Call Gril 80022//12248 Only For Sex And High Profile Best Gril Sex Av...Chennai Call Gril 80022//12248 Only For Sex And High Profile Best Gril Sex Av...
Chennai Call Gril 80022//12248 Only For Sex And High Profile Best Gril Sex Av...
 
Nashik Call Girl Just Call 7091819311 Top Class Call Girl Service Available
Nashik Call Girl Just Call 7091819311 Top Class Call Girl Service AvailableNashik Call Girl Just Call 7091819311 Top Class Call Girl Service Available
Nashik Call Girl Just Call 7091819311 Top Class Call Girl Service Available
 
Berhampur CALL GIRL❤7091819311❤CALL GIRLS IN ESCORT SERVICE WE ARE PROVIDING
Berhampur CALL GIRL❤7091819311❤CALL GIRLS IN ESCORT SERVICE WE ARE PROVIDINGBerhampur CALL GIRL❤7091819311❤CALL GIRLS IN ESCORT SERVICE WE ARE PROVIDING
Berhampur CALL GIRL❤7091819311❤CALL GIRLS IN ESCORT SERVICE WE ARE PROVIDING
 
Berhampur Call Girl Just Call 8084732287 Top Class Call Girl Service Available
Berhampur Call Girl Just Call 8084732287 Top Class Call Girl Service AvailableBerhampur Call Girl Just Call 8084732287 Top Class Call Girl Service Available
Berhampur Call Girl Just Call 8084732287 Top Class Call Girl Service Available
 
Dr. Admir Softic_ presentation_Green Club_ENG.pdf
Dr. Admir Softic_ presentation_Green Club_ENG.pdfDr. Admir Softic_ presentation_Green Club_ENG.pdf
Dr. Admir Softic_ presentation_Green Club_ENG.pdf
 
Berhampur 70918*19311 CALL GIRLS IN ESCORT SERVICE WE ARE PROVIDING
Berhampur 70918*19311 CALL GIRLS IN ESCORT SERVICE WE ARE PROVIDINGBerhampur 70918*19311 CALL GIRLS IN ESCORT SERVICE WE ARE PROVIDING
Berhampur 70918*19311 CALL GIRLS IN ESCORT SERVICE WE ARE PROVIDING
 
Al Mizhar Dubai Escorts +971561403006 Escorts Service In Al Mizhar
Al Mizhar Dubai Escorts +971561403006 Escorts Service In Al MizharAl Mizhar Dubai Escorts +971561403006 Escorts Service In Al Mizhar
Al Mizhar Dubai Escorts +971561403006 Escorts Service In Al Mizhar
 
Ooty Call Gril 80022//12248 Only For Sex And High Profile Best Gril Sex Avail...
Ooty Call Gril 80022//12248 Only For Sex And High Profile Best Gril Sex Avail...Ooty Call Gril 80022//12248 Only For Sex And High Profile Best Gril Sex Avail...
Ooty Call Gril 80022//12248 Only For Sex And High Profile Best Gril Sex Avail...
 
Lundin Gold - Q1 2024 Conference Call Presentation (Revised)
Lundin Gold - Q1 2024 Conference Call Presentation (Revised)Lundin Gold - Q1 2024 Conference Call Presentation (Revised)
Lundin Gold - Q1 2024 Conference Call Presentation (Revised)
 
UAE Bur Dubai Call Girls ☏ 0564401582 Call Girl in Bur Dubai
UAE Bur Dubai Call Girls ☏ 0564401582 Call Girl in Bur DubaiUAE Bur Dubai Call Girls ☏ 0564401582 Call Girl in Bur Dubai
UAE Bur Dubai Call Girls ☏ 0564401582 Call Girl in Bur Dubai
 
Cannabis Legalization World Map: 2024 Updated
Cannabis Legalization World Map: 2024 UpdatedCannabis Legalization World Map: 2024 Updated
Cannabis Legalization World Map: 2024 Updated
 
Paradip CALL GIRL❤7091819311❤CALL GIRLS IN ESCORT SERVICE WE ARE PROVIDING
Paradip CALL GIRL❤7091819311❤CALL GIRLS IN ESCORT SERVICE WE ARE PROVIDINGParadip CALL GIRL❤7091819311❤CALL GIRLS IN ESCORT SERVICE WE ARE PROVIDING
Paradip CALL GIRL❤7091819311❤CALL GIRLS IN ESCORT SERVICE WE ARE PROVIDING
 
QSM Chap 10 Service Culture in Tourism and Hospitality Industry.pptx
QSM Chap 10 Service Culture in Tourism and Hospitality Industry.pptxQSM Chap 10 Service Culture in Tourism and Hospitality Industry.pptx
QSM Chap 10 Service Culture in Tourism and Hospitality Industry.pptx
 
Organizational Transformation Lead with Culture
Organizational Transformation Lead with CultureOrganizational Transformation Lead with Culture
Organizational Transformation Lead with Culture
 
HomeRoots Pitch Deck | Investor Insights | April 2024
HomeRoots Pitch Deck | Investor Insights | April 2024HomeRoots Pitch Deck | Investor Insights | April 2024
HomeRoots Pitch Deck | Investor Insights | April 2024
 

The State of Clinical Development - Globalization

  • 1. The State of Clinical Development - Globalization January 11, 2011 Doug Peddicord, PhD Executive Director
  • 2.
  • 3. The Top CROs (as of 10-16-11) Sources: Scrip INC Kendle Pharmanet I3 InVentiv Health
  • 4. Major Pharma and CRO Clinical Headcount Source: Tufts CSDD analysis
  • 5. ACRO Member Company Expansion: 2010
  • 6. ACRO Member Company Expansion: 2011
  • 7. Increasing Global Site Dispersion Source: Tufts CSDD analysis of Industry-Funded Trials Registered on clinicaltrials.gov 2002-2006 (Mean # of Countries) 2006-2010 (Mean # of Countries) Phase I Clinical Trial 2 2 Phase II Clinical Trial 11 18 Phase III Clinical Trial 19 34
  • 8. A Global Enterprise – Current and Recently Completed Trials Source: ClinicalTrials.gov
  • 9.
  • 10.
  • 11.
  • 12.
  • 13.
  • 14.
  • 15.
  • 16. Comparison of Participating Sites and Subjects Across Various Regions
  • 17.
  • 18.
  • 19.
  • 20.
  • 21.
  • 22.

Hinweis der Redaktion

  1. As a note, our members have opened 35 new locations in the past five quarters, including 6 in China and 5 in India, so clearly drug development is headed more to the Asia-Pacific region.